B L Innis

Author PubWeight™ 100.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000 11.44
2 Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 1997 5.13
3 Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997 5.00
4 Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999 2.96
5 Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest 1991 2.37
6 HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 2002 2.18
7 Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 1988 2.03
8 Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest 1989 2.01
9 Impact of dengue virus infection on feeding behavior of Aedes aegypti. Am J Trop Med Hyg 1997 1.90
10 Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin Haematol 1995 1.80
11 Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine 2001 1.79
12 Detection of hepatitis E virus infections among domestic swine in the Kathmandu Valley of Nepal. Am J Trop Med Hyg 1995 1.67
13 Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg 2001 1.65
14 Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl 1994 1.61
15 Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2. J Med Virol 1995 1.58
16 High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg 1993 1.56
17 Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers. Vaccine 1996 1.51
18 Experimental infection of the laboratory rat with the hepatitis E virus. J Med Virol 1996 1.44
19 Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E. J Infect Dis 1995 1.40
20 Effect of size and geographic origin of Aedes aegypti on oral infection with dengue-2 virus. Am J Trop Med Hyg 1998 1.39
21 Sensitivity and specificity of a universal primer set for the rapid diagnosis of dengue virus infections by polymerase chain reaction and nucleic acid hybridization. Am J Trop Med Hyg 1991 1.38
22 Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 1995 1.30
23 Epidemic of adenovirus-induced respiratory illness among US military recruits: epidemiologic and immunologic risk factors in healthy, young adults. J Med Virol 2001 1.22
24 Correlation of E protein binding with cell susceptibility to dengue 4 virus infection. J Gen Virol 1992 1.16
25 Dengue infection complicated by severe hemorrhage and vertical transmission in a parturient woman. Clin Infect Dis 1994 1.15
26 Human immune responses to dengue viruses. Southeast Asian J Trop Med Public Health 1990 1.15
27 Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy. JAMA 1985 1.13
28 Distribution of dengue and Japanese encephalitis among children in rural and suburban Thai villages. Am J Trop Med Hyg 2001 1.13
29 An outbreak of hepatitis E in Northern Namibia, 1983. Am J Trop Med Hyg 2000 1.12
30 Phylogenetic analysis of hepatitis E virus isolates from Egypt. J Med Virol 1999 1.11
31 B cells are the principal circulating mononuclear cells infected by dengue virus. Southeast Asian J Trop Med Public Health 1999 1.09
32 Detection of adenoviruses (AdV) in culture-negative environmental samples by PCR during an AdV-associated respiratory disease outbreak. J Clin Microbiol 2000 1.09
33 Japanese encephalitis virus in Bangkok: factors influencing vector infections in three suburban communities. J Med Entomol 1992 1.08
34 Hepatitis E virus: complete genome sequence and phylogenetic analysis of a Nepali isolate. Virus Res 1998 1.07
35 Dengue 3 virus distribution in the mosquito Aedes aegypti: an immunocytochemical study. Med Vet Entomol 1996 1.07
36 Applications of polymerase chain reaction for identification of dengue viruses isolated from patient sera. Microbiol Immunol 1993 1.04
37 An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys. Am J Trop Med Hyg 1999 1.04
38 Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal. J Infect Dis 1997 1.02
39 Development of cross-reactive antibodies to plasminogen during the immune response to dengue virus infection. J Infect Dis 1991 0.99
40 Association of hepatitis E virus with an outbreak of hepatitis at a military training camp in Nepal. J Med Virol 1998 0.99
41 Seroprevalence of hepatitis E virus among United Nations Mission in Haiti (UNMIH) peacekeepers, 1995. Am J Trop Med Hyg 1998 0.98
42 Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines. Am J Trop Med Hyg 2003 0.95
43 T cell activation in vivo by dengue virus infection. J Clin Lab Immunol 1995 0.95
44 Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. Am J Trop Med Hyg 1995 0.94
45 A putative cellular receptor for dengue viruses. Nat Med 1997 0.93
46 Characterization of a genetic variant of human hepatitis A virus. J Med Virol 1992 0.92
47 Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice. Vaccine 2000 0.91
48 ELISA for detecting dengue and Japanese encephalitis viral antigen in mosquitoes. Ann Trop Med Parasitol 1994 0.91
49 Short report: phylogenetically distinct hepatitis E viruses in Pakistan. Am J Trop Med Hyg 2000 0.91
50 Murine typhus identified as a major cause of febrile illness in a camp for displaced Khmers in Thailand. Am J Trop Med Hyg 1990 0.90
51 Causes of death and unintentional injury among schoolchildren in Thailand. Southeast Asian J Trop Med Public Health 1999 0.89
52 Molecular characterization of a hepatitis E virus isolate from Namibia. J Biomed Sci 2000 0.89
53 Antiserum generated by DNA vaccine binds to hepatitis E virus (HEV) as determined by PCR and immune electron microscopy (IEM): application for HEV detection by affinity-capture RT-PCR. Virus Res 1999 0.88
54 A purified inactivated Japanese encephalitis virus vaccine made in Vero cells. Vaccine 2001 0.87
55 Association of hepatitis E virus with an outbreak of hepatitis in Pakistan: serologic responses and pattern of virus excretion. J Med Virol 1992 0.85
56 Atypical antibody responses in dengue vaccine recipients. Am J Trop Med Hyg 2003 0.84
57 Limited potential for transmission of live dengue virus vaccine candidates by Aedes aegypti and Aedes albopictus. Am J Trop Med Hyg 2000 0.84
58 Virus-like particles in the liver of a patient with fulminant hepatitis and antibody to hepatitis E virus. J Med Virol 1990 0.83
59 Hepatitis E virus DNA vaccine elicits immunologic memory in mice. J Biomed Sci 2001 0.82
60 Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus. Vaccine 2000 0.82
61 Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis virus. Am J Trop Med Hyg 1999 0.80
62 Hepatitis B virus infection in Thai children. Trop Med Int Health 2000 0.79
63 The socioeconomic impact of hepatitis E in Nepal. Am J Trop Med Hyg 1999 0.79
64 Hepatitis A in the US Army: epidemiology and vaccine development. Vaccine 1992 0.78
65 Hepatitis E virus in Nepal: similarities with the Burmese and Indian variants. Virus Res 1997 0.78
66 Short report: relative risk of hepatitis A and E among foreigners in Nepal. Am J Trop Med Hyg 1995 0.77
67 Genotyping of hepatitis E virus in clinical specimens by restriction endonuclease analysis. J Virol Methods 1998 0.77
68 Solid-phase antibody capture hemadsorption assay for detection of hepatitis A virus immunoglobulin M antibodies. J Clin Microbiol 1993 0.77
69 Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys. Am J Trop Med Hyg 1999 0.77
70 Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation. Transpl Infect Dis 2014 0.75
71 A cluster of acute hepatitis E infection in United Nations Bangladeshi peacekeepers in Haiti. Am J Trop Med Hyg 1997 0.75
72 Hepatitis E vaccine for travelers? J Travel Med 2000 0.75
73 A novel method for the preparation of large cDNA fragments from dengue-3 RNA genome by long RT-PCR amplification. Southeast Asian J Trop Med Public Health 2000 0.75
74 Highly conserved nucleotide sequence and its deduced amino acids of the 5'-noncoding region and the capsid protein of a Bangkok isolate dengue-3 virus. Southeast Asian J Trop Med Public Health 2000 0.75
75 Identification of hepatitis E virus in clinical specimens: amplification of hydroxyapatite-purified virus RNA and restriction endonuclease analysis. J Virol Methods 1997 0.75
76 Nucleotide sequence and deduced amino acid sequence of the nonstructural proteins of dengue type 3 virus, Bangkok genotype. Southeast Asian J Trop Med Public Health 1998 0.75